InnovAge Holding Corp. (INNV) Operating Margin
- Operating margin · 12 months: Value 0.26%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 0.26% | Operating income / revenue. Period ending 2026-06-30. $2.62M ÷ $989.71M × 100 ≈ 0.26% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 2.62M USD | Operating Income (Loss) |
| Revenue | 989.71M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.62M | $989.71M | (m) | (m) | (m) | 0.26% |
| 2026-03-31 | $-9.68M | $949.17M | (m) | (m) | (m) | -1.02% |
| 2025-12-31 | $9.24M | $915.37M | (m) | (m) | (m) | 1.01% |
| 2025-09-30 | $-16.58M | $884.66M | (m) | (m) | (m) | -1.87% |
| 2025-06-30 | $-29.76M | $853.70M | (m) | (m) | (m) | -3.49% |
| 2025-03-31 | $-32.49M | $831.68M | (m) | (m) | (m) | -3.91% |
| 2024-12-31 | $-28.13M | $806.61M | (m) | (m) | (m) | -3.49% |
| 2024-09-30 | $-17.36M | $786.51M | (m) | (m) | (m) | -2.21% |
| 2024-06-30 | $-23.18M | $763.86M | (m) | (m) | (m) | -3.03% |
| 2024-03-31 | $-29.24M | $741.33M | (m) | (m) | (m) | -3.94% |
| 2023-12-31 | $-31.61M | $720.79M | (m) | (m) | (m) | -4.39% |
| 2023-09-30 | $-43.51M | $699.35M | (m) | (m) | (m) | -6.22% |
| 2023-06-30 | $-49.40M | $688.09M | (m) | (m) | (m) | -7.18% |
| 2023-03-31 | $-50.80M | $684.07M | (m) | (m) | (m) | -7.43% |
| 2022-12-31 | $-49.30M | $688.89M | (m) | (m) | (m) | -7.16% |
| 2022-09-30 | $-32.67M | $696.79M | (m) | (m) | (m) | -4.69% |
| 2022-06-30 | $-4.41M | $698.64M | (m) | (m) | (m) | -0.63% |
| 2022-03-31 | $18.61M | $697.40M | (m) | (m) | (m) | 2.67% |
| 2021-12-31 | $19.91M | $676.34M | (m) | (m) | (m) | 2.94% |
| 2021-09-30 | $37.50M | $658.30M | (m) | (m) | (m) | 5.70% |
| 2021-06-30 | $-12.34M | $637.80M | (m) | (m) | (m) | -1.93% |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $50.93M | $567.19M | (m) | (m) | (m) | 8.98% |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |